Colorectal Dysplasia and Cancer in Pediatric-onset Ulcerative Colitis Associated with Primary Sclerosing Cholangitis.
暂无分享，去创建一个
T. Miloh | N. Kerkar | S. Guthery | N. Gupta | Mercedes Martinez | E. Perito | B. Koot | K. Furuya | S. Horslen | K. Schwarz | K. Loomes | W. El-Matary | C. Mack | N. Ovchinsky | P. Sathya | Ruchi Singh | A. Miethke | L. Draijer | M. Deneau | P. Valentino | A. Amir | A. Ricciuto | U. Shah | D. Mogul | Nisreen Soufi | Trevor J. Laborda | Matthew DiGuglielmo | A. Zizzo | Jessica T. Hochberg | Girish S Rao | S. Moroz | Saeeda R Mohammed
[1] Harminder Singh,et al. Long-term Cancer Risk in Patients With Pediatric-onset Inflammatory Bowel Diseases in the Canadian Population. , 2020, Gastroenterology.
[2] F. Gottrand,et al. Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis , 2018, Hepatology communications.
[3] G. Veres,et al. Malignancy and mortality in paediatric‐onset inflammatory bowel disease: a 3‐year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN , 2018, Alimentary Pharmacology and Therapeutics.
[4] N. Harpaz,et al. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[5] F. Gottrand,et al. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration , 2017, Hepatology.
[6] P. Heidenreich,et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. , 2002, Gastrointestinal endoscopy.
[7] F. Vleggaar,et al. High lifetime risk of cancer in primary sclerosing cholangitis. , 2009, Journal of hepatology.